A subsidiary of medical research firm DNAnexus provided the cash for the Google-backed genome data platform as part of a strategic agreement.
Wuxi NextCode, a genome technology subsidiary of medical research company Wuxi PharmaTech, invested $15m in US-based genome data management company DNAnexus yesterday as part of a strategic alliance.
Founded in 2009, DNAnexus combines cloud computing and bioinformatics in a global database for genomic medicine. The partnership will enable the company’s platform to expand to China while also securing greater access to Chinese genomics technology.
Richard Daly, chief executive of DNAnexus, said: “Our customers are global in scope, and we’re teaming…
